Astragaloside IV protects against lung injury and pulmonary fibrosis in COPD by targeting GTP-GDP domain of RAS and downregulating the RAS/RAF/FoxO signaling pathway
Man Zhang, Wenshuang Wang, Kaixin Liu, Chao Jia, Yuanyuan Hou, Gang Bai
Topics & Concepts
COPDPulmonary fibrosisLungMedicineIdiopathic pulmonary fibrosisPharmacologyFibrosisCancer researchPathologyImmunologyInternal medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisTraditional Chinese Medicine AnalysisCardiac Fibrosis and Remodeling